Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2004.04.018
Annals of Surgical Oncology 11:506-511 (2004)
© 2004 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bollschweiler, E. H.
Right arrow Articles by Hölscher, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bollschweiler, E. H.
Right arrow Articles by Hölscher, A. H.

ORIGINAL ARTICLES

Artificial Neural Network for Prediction of Lymph Node Metastases in Gastric Cancer: A Phase II Diagnostic Study

Elfriede H. Bollschweiler, MD, Stefan P. Mönig, MD, Karin Hensler, MD, Stephan E. Baldus, MD, Keiichi Maruyama, MD and Arnulf H. Hölscher, MD, FACS, FRCS

From the Department of Visceral and Vascular Surgery, University of Cologne, Germany (EHB, SPM, KH, AHH); Institute of Pathology, University of Cologne, Germany (SEB); and Department of Surgical Oncology, University of Health and Welfare, Sanno Hospital, Tokyo, Japan (KM).

Correspondence: Address correspondence and reprint requests to: Elfriede Bollschweiler, MD, Klinik und Poliklinik für Visceral und Gefäßchirurgie, der Universität zu Köln, Joseph Stelzmann Straße 9, 50931 Köln, Germany; Fax: 49-221-478-5076; E-mail: elfriede.bollschweiler{at}medizin.uni-koeln.de

Background: Extension of lymphadenectomy in gastric cancer is controversial, and preoperative diagnosis of lymph node metastases (LNM) is difficult. Therefore, knowledge-based systems such as the Maruyama computer program (MCP) are being developed. MCP shows good prognostic value for the compartments; however, for different lymph node groups (LNG) there are a large number of false positives. The aim of this study was to evaluate artificial neural networks (ANN) for predicting LNM in patients with gastric cancer and to compare the predictive power with that of MCP.

Methods: A total of 135 consecutive patients who underwent D2 gastrectomy were included. We applied a single-layer perceptron to the data of 4302 patients from the National Cancer Center, Tokyo, and compared the results with those from the MCP.

Results: Prediction of N+ or N0 with ANN-1 (Borrmann classification, T category, and tumor size and location) had an accuracy of 79%. The predictive value for LNM in each of the LNG varied: ANN-1, 64% to 86%; MCP, 42% to 70%. We constructed another ANN by using the additional parameter of metastases in LNG 3 as an example of sentinel node. The accuracy of this ANN was 93%.

Conclusions: Using an ANN, LNM in each LNG can be accurately predicted. Additional knowledge about one lymph node improves the results.

Key Words: Artificial neural network • Gastric cancer • Lymph node metastases • Sentinel lymph node • Diagnostic study




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
L. F. Onate-Ocana, V. Aiello-Crocifoglio, D. Gallardo-Rincon, R. Herrera-Goepfert, R. Brom-Valladares, J. F. Carrillo, E. Cervera, and A. Mohar-Betancourt
Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma
Ann. Surg. Oncol., February 1, 2007; 14(2): 381 - 389.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
R. N. Dickerson, D. L. Mason, M. A. Croce, G. Minard, and R. O. Brown
Evaluation of an Artificial Neural Network to Predict Urea Nitrogen Appearance for Critically Ill Multiple-Trauma Patients
JPEN J Parenter Enteral Nutr, November 1, 2005; 29(6): 429 - 435.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society of Surgical Oncology.